Remote arm‑cuff conditioning plus stent placement for symptomatic carotid narrowing
Official title: Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis (RICSICAS): A Prospective, Randomized Controlled, Blind Endpoint, Single-Center Study
Run by General Hospital of Shenyang Military Region · NCT07412249 · Data updated 2026-11-12
This study tests whether regular remote limb ischemic conditioning after carotid artery stenting can lower major vascular events and improve outcomes for adults with symptomatic carotid artery narrowing.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | General Hospital of Shenyang Military Region Academic / other |
| Locations | 1 site (Shenyang) |
| Status | Recruiting |
| Started | March 4, 2026 |
| Main results expected | November 30, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT07412249 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40 or older with symptomatic moderate-to-severe internal carotid artery stenosis, ipsilateral ischemic symptoms within the past 180 days, an Essen score ≥ 3, a modified Rankin Scale of 0–1, and a planned carotid artery stent are ideal candidates.
✕Probably not a fit
Patients with contraindications to RIC (for example significant peripheral or upper-limb vascular disease, severe soft tissue injury or fracture of the arm), uncontrolled severe hypertension, significant subclavian stenosis/steal, severe hematologic or coagulation disorders, very limited life expectancy, or who do not have recent symptomatic carotid stenosis may not receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls adults with recent ipsilateral cerebral ischemic symptoms and moderate-to-severe internal carotid artery stenosis who are scheduled for carotid artery stenting, and applies chronic remote ischemic conditioning after the procedure while monitoring patients over the long term. Remote ischemic conditioning (RIC) is a non-invasive approach that uses brief, repeated limb ischemia cycles to trigger protective mechanisms in the brain. The trial tracks incidence of major vascular events and clinical functional outcomes and records safety data related to prolonged RIC use. Results will determine whether chronic RIC adds long-term benefit to patients who receive carotid stents.
Why it matters
Potential benefit: If successful, this approach could reduce major vascular events and improve recovery and long-term function after carotid artery stenting.
How similar studies have gone: Smaller and short-term studies of remote ischemic conditioning in stroke and in patients undergoing carotid procedures have suggested potential benefit, but long-term efficacy and safety after carotid stenting remain unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 40 years old; * Patients with symptomatic moderate to severe stenosis of the internal carotid artery; * History of ipsilateral cerebral ischemic symptoms within the past 180 days; * Planned for carotid artery stent; * Essen Score ≥ 3; * Modified Rankin Scale score of 0 or 1; * Signed informed consent. Exclusion Criteria: * Uncontrolled severe hypertension (systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 110 mmHg despite medication) * Subclavian artery stenosis ≥ 50% or presence of subclavian steal syndrome * Severe hematological disorders or significant coagulation abnormalities * Contraindications to remote ischemic conditioning, such as severe soft tissue injury, fracture, or vascular injury in the upper limbs, or peripheral vascular disease in the distal upper limbs * Severe comorbid conditions with a life expectancy of less than 1 year * Participation in another clinical trial within the past 3 months or ongoing participation * Any other circumstances deemed by the investigator as unsuitable for participation in this clinical study.
Where it's running
-
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, China Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Will GFAP in the blood after carotid endarterectomy predict neurological problems?
This study tests whether blood GFAP levels before and after carotid endarterectomy relate to postoperative neurological issues in adults.
-
Residual and recurrent carotid narrowing after endarterectomy with primary closure
The study will test how often and when carotid narrowing comes back after elective carotid endarterectomy with primary closure in adults.
-
Managing asymptomatic carotid stenosis to prevent strokes
This study looks at whether surgery to clear blocked neck arteries can help older patients with no symptoms avoid strokes.
-
Selective coronary revascularization for patients with carotid artery disease after carotid surgery
This study is testing if adding a specific heart procedure to the best medical treatment can help prevent heart problems in patients over 50 who have had surgery for carotid artery disease.
-
Carotid artery stenting during treatment of acute stroke
This study is testing if adding carotid artery stenting during a stroke treatment can help improve blood flow to the brain and lower the chances of having another stroke for patients with blocked carotid arteries.
-
Investigating the role of ficolin-2 in carotid stenosis and brain inflammation
This study is testing if a specific biomarker can help identify dangerous plaque in the carotid artery of patients who have had a mini-stroke or stroke, to see if they might benefit from a procedure to improve blood flow.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.